Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Smallridge

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
European Journal of Endocrinology|September 1, 1996
Immunoglobulins from Graves' disease patients stimulate phospholipase A2 and C systems in FRTL-5 and human thyroid cellsM A Atwa, R C Smallridge, H B Burch, et al.
Brain Research|September 25, 1995
Phospholipase A2-induced neurotoxicity in vitro and in vivo in ratsL E Clapp, K L Klette, M A DeCoster, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroidD L Segev, M Saji, G S Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2007
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinomaS J Silverberg, M R Rubin, C Faiman, et al.
Oncogene|December 7, 2005
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1J A Copland, L A Marlow, S Kurakata, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trialR C Smallridge, J A Copland, M S Brose, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
European Journal of Endocrinology|September 1, 1996
Immunoglobulins from Graves' disease patients stimulate phospholipase A2 and C systems in FRTL-5 and human thyroid cellsM A Atwa, R C Smallridge, H B Burch, et al.
Brain Research|September 25, 1995
Phospholipase A2-induced neurotoxicity in vitro and in vivo in ratsL E Clapp, K L Klette, M A DeCoster, et al.
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroidD L Segev, M Saji, G S Phillips, et al.
The Journal of Clinical Endocrinology and Metabolism|August 2, 2007
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinomaS J Silverberg, M R Rubin, C Faiman, et al.
Oncogene|December 7, 2005
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1J A Copland, L A Marlow, S Kurakata, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2013
Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trialR C Smallridge, J A Copland, M S Brose, et al.
Pageof 13